MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$64,542K
(-8.63%↓ Y/Y)
Loss before income
taxes
-$64,542K
(-8.63%↓ Y/Y)
Product
$189,400K
(57.36%↑ Y/Y)
Royalty And Milestone
Revenue
$1,803K
Loss from operations
-$63,357K
(-11.19%↓ Y/Y)
Interest expense, net
-$1,185K
(51.25%↑ Y/Y)
Revenue
$191,203K
(57.42%↑ Y/Y)
Total operating
expenses
$254,560K
(42.65%↑ Y/Y)
Selling, general and
administrative
$184,996K
(53.16%↑ Y/Y)
Research and development
$52,677K
(17.62%↑ Y/Y)
Cost of revenue
(excluding amortization...
$14,725K
(50.42%↑ Y/Y)
Intangible asset
amortization
$1,572K
(0.00%↑ Y/Y)
Loss in fair value of
contingent consideration
$590K
(-60.98%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM)